Szu-Huei Wu

发表

Discovery of non-glycoside sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors by ligand-based virtual screening.

Yi-Hui Peng, C. Chen, Y. Chao, 2010, Journal of medicinal chemistry.

Fast-forwarding hit to lead: aurora and epidermal growth factor receptor kinase inhibitor lead identification.

Santhosh Kumar Chittimalla, Yi-Hui Peng, H. Hsieh, 2010, Journal of medicinal chemistry.

A Novel Dengue Virus Inhibitor, BP13944, Discovered by High-Throughput Screening with Dengue Virus Replicon Cells Selects for Resistance in the Viral NS2B/NS3 Protease

A. Yueh, Szu-Huei Wu, Shiow-Ju Lee, 2013, Antimicrobial Agents and Chemotherapy.

Novel Dengue Virus-Specific NS2B/NS3 Protease Inhibitor, BP2109, Discovered by a High-Throughput Screening Assay

A. Yueh, Y. Chao, Szu-Huei Wu, 2010, Antimicrobial Agents and Chemotherapy.

Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identification

Yung Chang Hsu, H. Hsieh, J. Hsu, 2015, Scientific Reports.

A cell-based high-throughput screen for epidermal growth factor receptor pathway inhibitors.

H. Hsieh, T. Lien, Y. Chao, 2008, Analytical biochemistry.

Ligand efficiency based approach for efficient virtual screening of compound libraries.

H. Hsieh, J. Hsu, Szu-Huei Wu, 2014, European journal of medicinal chemistry.

N-Indolylglycosides bearing modifications at the glucose C6-position as sodium-dependent glucose co-transporter 2 inhibitors.

C. Chen, Y. Chao, Szu-Huei Wu, 2016, Bioorganic & medicinal chemistry.

Development and application of a fluorescent glucose uptake assay for the high-throughput screening of non-glycoside SGLT2 inhibitors.

Y. Chao, Chieh-Jui Hsieh, Szu-Huei Wu, 2015, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Remdesivir and Cyclosporine Synergistically Inhibit the Human Coronaviruses OC43 and SARS-CoV-2

C. Chen, Szu-Huei Wu, Shiow-Ju Lee, 2021, Frontiers in Pharmacology.

A high-throughput cell-based screening for L858R/T790M mutant epidermal growth factor receptor inhibitors.

H. Hsieh, T. Lien, Y. Chao, 2012, Anticancer research.

Repurposing old drugs as antiviral agents for coronaviruses

C. Chen, Szu-Huei Wu, Shiow-Ju Lee, 2020, Biomedical Journal.

Stem cell mobilizers targeting chemokine receptor CXCR4: renoprotective application in acute kidney injury.

C. Chen, Szu-Huei Wu, Jen‐Shin Song, 2015, Journal of medicinal chemistry.

Synthesis and biological evaluation of N-glucosyl indole derivatives as sodium-dependent glucose co-transporter 2 inhibitors.

C. Chen, Y. Chao, Szu-Huei Wu, 2019, Bioorganic chemistry.

Identification of an oxime-containing C-glucosylarene as a potential inhibitor of sodium-dependent glucose co-transporter 2.

C. Chen, Y. Chao, Szu-Huei Wu, 2018, European journal of medicinal chemistry.

Synthesis and biological evaluation of novel C-aryl d-glucofuranosides as sodium-dependent glucose co-transporter 2 inhibitors.

Szu-Huei Wu, Jen‐Shin Song, P. Liang, 2013, Bioorganic & medicinal chemistry.

Protective Effect of CXCR4 Antagonist DBPR807 against Ischemia-Reperfusion Injury in a Rat and Porcine Model of Myocardial Infarction: Potential Adjunctive Therapy for Percutaneous Coronary Intervention

C. Chen, Szu-Huei Wu, Jen‐Shin Song, 2022, International journal of molecular sciences.

Discovery of novel N-β-D-xylosylindole derivatives as sodium-dependent glucose cotransporter 2 (SGLT2) inhibitors for the management of hyperglycemia in diabetes.

C. Chen, Y. Chao, Chieh-Jui Hsieh, 2011, Journal of medicinal chemistry.

Inhibition of SARS-CoV-2 by Highly Potent Broad-Spectrum Anti-Coronaviral Tylophorine-Based Derivatives

C. Chen, Szu-Huei Wu, J. Jan, 2020, Frontiers in Pharmacology.

Chemical and cytotoxic constituents from Peperomia sui.

B. Jayaprakasam, Szu-Huei Wu, I. Chen, 2003, Phytochemistry.

trans‐Stilbene C‐Glycosides: Synthesis by a Microwave‐Assisted Heck Reaction and Evaluation of the SGLT‐2 Inhibitory Activity

Szu-Huei Wu, Jen‐Shin Song, Chun‐Cheng Lin, 2017 .

Artificial intelligence approach fighting COVID-19 with repurposing drugs

Huey-Kang Sytwu, Wen-Hsing Lin, Szu-Huei Wu, 2020, Biomedical Journal.

A novel flavivirus entry inhibitor, BP34610, discovered through high-throughput screening with dengue reporter viruses.

C. Chen, A. Yueh, Szu-Huei Wu, 2019, Antiviral research.

Synthesis and biological evaluation of novel C-indolylxylosides as sodium-dependent glucose co-transporter 2 inhibitors.

C. Chen, Szu-Huei Wu, Jen‐Shin Song, 2012, European journal of medicinal chemistry.

Design, Synthesis, and Evaluation of Thiazolidine-2,4-dione Derivatives as a Novel Class of Glutaminase Inhibitors.

C. Chen, Szu-Huei Wu, Jen‐Shin Song, 2017, Journal of medicinal chemistry.

Discovery of M Protease Inhibitors Encoded by SARS-CoV-2

C. Chen, J. Hsu, Szu-Huei Wu, 2020, Antimicrobial Agents and Chemotherapy.

Design, synthesis, and anticancer evaluation of 1-benzo[1,3]dioxol-5-yl-3-N-fused heteroaryl indoles.

Szu-Huei Wu, Jen‐Shin Song, Mine-Hsine Wu, 2023, Molecular diversity.

Characterization of an efficient dengue virus replicon for development of assays of discovery of small molecules against dengue virus.

A. Yueh, Y. Chao, Szu-Huei Wu, 2013, Antiviral research.

Discovery of Novel Stem Cell Mobilizers That Target the CXCR4 Receptor

C. Chen, Y. Chao, Su-Ying Wu, 2012, ChemMedChem.